Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DB26FY1K1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,341
Award facts
- Contract value 100% obligated
- $22,341.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of SKYRIZI 150 mg/mL in pen form, valued at $22,341.08. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle valued through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. SKYRIZI is a specialty biologic medication used in dermatological treatment, reflecting the company's extensive portfolio of brand-name and generic medications across multiple therapeutic domains. The supply of this specialty pharmaceutical through DLA's medical supply chain supports the Defense Health Agency and other government healthcare systems requiring specialized medical commodities. AmerisourceBergen's consistent receipt of competitive delivery orders under its prime IDV demonstrates the company's capability to fulfill federal medical procurement requirements efficiently across a broad range of pharmaceutical products and therapeutic areas.
Quick answers
Who was awarded contract SPE2DB26FY1K1?
SPE2DB26FY1K1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FY1K1 worth?
The government has obligated $22,341 on SPE2DB26FY1K1.
Is contract SPE2DB26FY1K1 an order under another contract?
Yes. SPE2DB26FY1K1 is a delivery order under SPE2DB20D3303, an indefinite delivery contract.
Was contract SPE2DB26FY1K1 competed?
The extent of competition for SPE2DB26FY1K1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award